Henry Schein, Inc.
NASDAQ:HSICMedical - Distribution
-$1.24 today
- Market cap
- $9.47B
- Beta
- 0.82
- P/E (TTM)
- 23.3
- EPS (TTM)
- $3.44
Volume 2.08M
Average 1.39M
HSIC Accounts Payables
Cash effect of the change in amounts owed to suppliers; growing payables preserve cash.
Henry Schein, Inc.NASDAQ: HSIC
Accounts Payables · Q2 FY2026 · quarter ended Jun 2026
Accounts payables outflow shrinks to $0
Q2 FY2026 accounts payables was $0, compared with $18M a year earlier. Trailing-twelve-month accounts payables was $310M.
Context
- Accounts payables amounted to 1.6% of revenue in FY2025, up 0.4 pp from a year earlier.
- Accounts payables increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly accounts payables holds near $0 or moves back toward the trailing-twelve-month quarterly average of $77.5M.
Sources:Cash FlowText generated from reported figures; not investment advice.
Accounts Payables history
USD · from the cash flow
- Latest · FY2025
- 216M USD
- Year-over-year change
- +232.5%
- 4-year CAGR
- +26.4%
| Period | Period end | Accounts Payables | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-27 | 216M | +232.5% |
| FY2024 | 2024-12-28 | (163M) | — |
| FY2023 | 2023-12-31 | 0 | +100.0% |
| FY2022 | 2022-12-31 | (96M) | -213.3% |
| FY2021 | 2021-12-31 | 84.71M | — |
Accounts Payables vs competitors
How HSIC compares with its peers on the latest reported figures
- HSIC's LTM Jun 2026 accounts payables of $310M is the 4th largest of the 7 companies compared; the peer median is $1.99B.
- Its year-over-year change of +785.7% is the highest of 7, against a peer median of +68.1%.
- Accounts payables amounts to 2.3% of revenue for HSIC, versus a peer median of 1.4%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $6.14B | +215.5% | +4.5% | 1.5% | |
| LTM Jun 2026 | $4.39B | +453.0% | +3.6% | 1.3% | |
| LTM Sep 2026 | $3.97B | -36.7% | +7.1% | 1.5% | |
| LTM Jun 2026 | $310M | +785.7% | — | 2.3% | |
| LTM Mar 2026 | $142.42M | -183.8% | -22.0% | 5.2% | |
| LTM Oct 2026 | $14.3M | +173.0% | -44.8% | 0.5% | |
| LTM Mar 2026 | $1M | -108.3% | -28.4% | 0.0% | |
| Peer median (excluding HSIC) | $1.99B | +68.1% | -9.2% | 1.4% | |
Competitors are the stored peer set for HSIC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 660.53M | 566M | 416M | 398M | 398M |
| Depreciation & Amortization | 209.53M | 212M | 222M | 268M | 311M |
| Deferred Income Tax | (12.93M) | (61M) | 0 | (56M) | 5M |
| Stock-Based Compensation | 78M | 54M | 39M | 39M | 0 |
| Change in Working Capital | (197.2M) | (281M) | (234M) | 140M | (48M) |
| Accounts Receivables | 4.16M | (7M) | (327M) | 315M | (124M) |
| Inventory | (295.13M) | (126M) | 231M | (59M) | (95M) |
| Accounts Payables | 84.71M | (96M) | 0 | (163M) | 216M |
| Other Working Capital | 9.06M | (52M) | (138M) | 47M | (45M) |
| Other Non-Cash Items | (28.34M) | 112M | 57M | 59M | 46M |
| Operating Cash Flow | 709.58M | 602M | 500M | 848M | 712M |
| Capital Expenditures | (79.02M) | (96M) | (187M) | (187M) | (139M) |
| Acquisitions (Net) | (560.8M) | (158M) | (955M) | (230M) | (276M) |
| Purchases of Investments | (7.32M) | (11M) | 0 | 0 | 0 |
| Sales of Investments | 7.32M | 11M | 22M | 4M | 0 |
| Other Investing Activities | (37.4M) | (22M) | (55M) | (56M) | (10M) |
| Investing Cash Flow | (677.22M) | (276M) | (1.14B) | (430M) | (477M) |
| Debt Repayment | 165M | 259M | 900M | 189M | 551M |
| Common Stock Issued | 0 | 0 | 0 | 0 | 252M |
| Common Stock Repurchased | (401M) | (485M) | (284M) | (385M) | (850M) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (88.96M) | (57M) | 85M | (314M) | (64M) |
| Financing Cash Flow | (332.96M) | (315M) | 701M | (510M) | (111M) |
| Effect of Forex Changes | (2.63M) | (12M) | (12M) | 43M | (90M) |
| Net Change in Cash | (303.22M) | (1M) | 54M | (49M) | 34M |
| Free Cash Flow | 630.57M | 506M | 313M | 661M | 573M |
Henry Schein, Inc.
NASDAQ:HSIC
Intrinsic Alpha fair value
Locked
Current Price
$85.69
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.